share_log

JP Morgan Maintains Overweight on SpringWorks Therapeutics, Raises Price Target to $74

Moomoo 24/7 ·  Mar 6 06:38

JP Morgan analyst Anupam Rama maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target from $73 to $74.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment